HomePMN • NASDAQ
Promis Neurosciences Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.46M | 380.41% |
Net income | -7.35M | -102.14% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.40M | 232.00% |
Total assets | 13.65M | 284.60% |
Total liabilities | 4.17M | 20.27% |
Total equity | 9.47M | — |
Shares outstanding | 32.69M | — |
Price to book | 1.74 | — |
Return on assets | -114.57% | — |
Return on capital | -143.68% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -7.35M | -102.14% |
Cash from operations | -4.93M | 52.13% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.93M | 51.22% |
Free cash flow | -2.49M | 72.46% |
Previous close
$0.51
Day range
$0.50 - $0.54
Year range
$0.47 - $2.37
Market cap
17.16M USD
Avg Volume
49.71K
P/E ratio
5.05
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
8